NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of GitLab Inc. (NASDAQ: GTLB) between June 6, 2023 and March 4, 2024, both dates inclusive (the "Class Period"), of the important November 4, 2024 lead plaintiff deadline. SO WHAT: If you purchased GitLab securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NE ...

NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Paragon 28, Inc. (NYSE: FNA) between May 5, 2023 and August 8, 2024, both dates inclusive (the "Class Period"), and those who purchased Paragon 28 call options or sold put options during the Class Period, of the November 29, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Paragon 28 securities during the Class ...

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of STMicroelectronics N.V. (NYSE: STM) between January 25, 2024 and July 24, 2024, both dates inclusive (the "Class Period"), of the important October 22, 2024 lead plaintiff deadline. SO WHAT: If you purchased STMicroelectronics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee a ...

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Endava plc (NYSE: DAVA) between May 23, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important October 25, 2024 lead plaintiff deadline. SO WHAT: If you purchased Endava securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO N ...

文章核心观点 - ZoomInfo Technologies Inc.(NASDAQ: ZI)的Class A普通股在2020年11月10日至2024年8月5日期间(包括两个日期)的购买者可能有权获得赔偿,无需支付任何费用或成本[1][2][4] - 根据诉讼,在该期间内,被告做出了虚假和/或误导性陈述,和/或未能披露以下信息[4]: 1) ZoomInfo在该期间内的财务和运营业绩受到了新冠疫情的暂时性影响,拉动了对其数字联系信息数据库的需求[4] 2) ZoomInfo的大部分现有客户正试图大幅减少使用或完全放弃其产品[4] 3) ZoomInfo使用了操纵性和强制性的自动续约政策和诉讼威胁,迫使客户即使不想续约也不得不与其续约[4] 4) ZoomInfo的强制性客户保留策略严重损害了其客户关系、客户群和竞争优势,并在未来期间创造了客户合同续约的隐藏需求悬崖[4] 5) 由于上述所有原因,ZoomInfo报告的收入、营业利润和客户及保留指标都被严重高估了[4] 根据相关目录分别进行总结 文章概述 - 罗森律师事务所提醒ZoomInfo Technologies Inc.(NASDAQ: ZI)的Class A普通股在2020年11月10日至2024年8月5日期间(包括两个日期)的购买者,重要的集体诉讼提起截止日期为2024年11月4日[1][2] - 如果您在该期间内购买了ZoomInfo的Class A普通股,您可能有权获得赔偿,无需支付任何费用或成本[1][2] 诉讼详情 - 根据诉讼,被告在该期间内做出了虚假和/或误导性陈述,和/或未能披露以下信息[4]: 1) ZoomInfo在该期间内的财务和运营业绩受到了新冠疫情的暂时性影响,拉动了对其数字联系信息数据库的需求[4] 2) ZoomInfo的大部分现有客户正试图大幅减少使用或完全放弃其产品[4] 3) ZoomInfo使用了操纵性和强制性的自动续约政策和诉讼威胁,迫使客户即使不想续约也不得不与其续约[4] 4) ZoomInfo的强制性客户保留策略严重损害了其客户关系、客户群和竞争优势,并在未来期间创造了客户合同续约的隐藏需求悬崖[4] 5) 由于上述所有原因,ZoomInfo报告的收入、营业利润和客户及保留指标都被严重高估了[4] 加入集体诉讼 - 如果您在该期间内购买了ZoomInfo的Class A普通股,您可以通过以下方式加入集体诉讼[2][5][6][7]: 1) 访问https://rosenlegal.com/submit-form/?case_id=28554 2) 致电Phillip Kim律师,免费电话866-767-3653 3) 发送电子邮件至case@rosenlegal.com

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Iris Energy Limited (NASDAQ: IREN) between June 20, 2023 and July 11, 2024, both dates inclusive (the "Class Period"). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 6, 2024 in the securities class action first filed by the Firm. SO WHAT: If ...

文章核心观点 - 美国Rosen律师事务所提醒Spire Global公司(NYSE: SPIR)在2024年3月6日至2024年8月14日期间的证券购买者,2024年10月21日是提名首席原告的最后期限 [1][3] - 如果投资者在该期间购买了Spire Global的证券,可能有资格获得赔偿,无需支付任何费用或成本 [1] - 该公司被指在该期间内做出了虚假和/或误导性陈述,并且未能披露某些合同中存在的租赁和预任务活动,导致收入被高估 [3] 公司情况总结 - Spire Global是一家在纽约证券交易所上市的公司 [1] - 该公司从事太空服务业务 [3] - 公司被指在某些合同中存在收入确认方面的内部控制问题,导致收入被高估 [3] 律所情况总结 - Rosen律师事务所是一家专注于证券集体诉讼和股东衍生诉讼的全球投资者权益律所 [2] - 该所在2017年被ISS证券集体诉讼服务评为证券集体诉讼和和解数量第一,并在之后几年一直排名前四 [2] - 该所在2019年单独为投资者赢得了4.38亿美元的和解金,在2020年其创始合伙人Laurence Rosen被评为原告律师界的泰坦 [2]

文章核心观点 - 根据诉讼,公司在2021年4月12日至2024年7月23日期间做出了虚假和/或误导性陈述,并未披露以下信息[3]: 1) 用于治疗产后抑郁(PD)和主要抑郁障碍(MDD)的zuranolone疗效低于公司向投资者宣称的水平 2) 因此,美国食品药品监督管理局(FDA)不太可能批准zuranolone用于治疗MDD的新药申请 3) SAGE-718(dalzanemdor)治疗帕金森病相关轻度认知障碍(MCI)的疗效低于公司宣称的水平 4) SAGE-324(BIIB124)治疗本发性震颤(ET)的疗效低于公司宣称的水平 - 当这些信息被披露后,投资者遭受损失[3] 公司概况 - Sage Therapeutics是一家专注于中枢神经系统疾病治疗的生物制药公司[1] - 公司主要产品包括用于治疗PD、MDD和ET的药物[3] 诉讼信息 - 罗森律师事务所代表2021年4月12日至2024年7月23日期间购买Sage证券的投资者提起集体诉讼[1] - 投资者可以通过https://rosenlegal.com/submit-form/?case_id=28360或致电Phillip Kim律师(866-767-3653)获取更多信息[4] - 截止日期为2024年10月28日,投资者可以申请成为首席原告代表集体利益进行诉讼[4]

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the "Class Period"), of the important October 28, 2024 lead plaintiff deadline in the securities class action first filed by the firm. SO WHAT: If you purchased Verve Therapeutics securities during the Class Period you may be entitled to compensation without payment of an ...

NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AMMO, Inc. (NASDAQ: POWW) between August 19, 2020 and September 24, 2024, both dates inclusive (the "Class Period"), of the important November 29, 2024 lead plaintiff deadline. SO WHAT: If you purchased AMMO securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO ...